Better access to diagnostic tests raises incidence of thyroid cancer in more affluent areas
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Wealthier Areas See Thyroid Cancer Rise Due to Test Access
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Rice-Led Center to Develop Budget Global Cancer Detection Tech
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
email article
The use of topical imiquimod was found to effectively promote regression of precancerous cervical lesions, according to a phase II randomized controlled trial.
In a per-protocol population of women with high-grade squamous intraepithelial lesions (HSIL) of the cervix, histologic regression of lesions was observed in 60.5% of patients receiving weekly treatment with imiquimod compared with just 22.5% in the control group (
P=0.001), resulting in a number needed to treat (NNT) of 2.63, reported Bruno O. Fonseca, MD, of Barretos Cancer Hospital in São Paulo, Brazil, and colleagues.
HSIL of the cervix, which are induced by human papillomavirus (HPV), are a precursor to cervical cancer. The standard treatment is surgical excision by either cold knife conization, laser conization, or a loop electrosurgical excision procedure (LEEP).